Carbon monoxide-releasing molecules (CO-RMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
The enzyme heme oxygenase-1 (HO-1) is a cytoprotective and anti-inflammatory protein that degrades heme to produce biliverdin/bilirubin, ferrous iron and carbon monoxide (CO). The anti-inflammatory properties of HO-1 are related to inhibition of adhesion molecule expression and reduction of oxidative stress, while exogenous CO gas treatment decreases the production of inflammatory mediators such as cytokines and nitric oxide (NO). CO-releasing molecules (CO-RMs) are a novel group of substances identified by our group that are capable of modulating physiological functions via the liberation of CO. We aimed in this study to examine the potential anti-inflammatory characteristics of CORM-2 and CORM-3 in an in vitro model of lipopolysaccharide (LPS)-stimulated murine macrophages. Stimulation of RAW264.7 macrophages with LPS resulted in increased expression of inducible NO synthase (iNOS) and production of nitrite. CORM-2 or CORM-3 (10-100 microM) reduced nitrite generation in a concentration-dependent manner but did not affect the protein levels of iNOS. CORM-3 also decreased nitrite levels when added 3 or 6 h after LPS exposure. CORM-2 or CORM-3 did not cause any evident cytotoxicity and produced an increase in HO-1 expression and heme oxygenase activity; this effect was completely prevented by the thiol donor N-acetylcysteine. CORM-3 also considerably reduced the levels of tumor necrosis factor-alpha, another mediator of the inflammatory response. The inhibitory effects of CORM-2 and CORM-3 were not observed when the inactive compounds, which do not release CO, were coincubated with LPS. These results indicate that CO liberated by CORM-2 and CORM-3 significantly suppresses the inflammatory response elicited by LPS in cultured macrophages and suggest that CO carriers can be used as an effective strategy to modulate inflammation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These observations suggest that NF-κB is activated because of a lack of HO-1 derived anti-inflammatory molecules (CO, bilirubin) and is consistent with previous findings showing that the CO releasing compound, CORM-2, inhibits the DNA binding activity of NF-κB resulting in reduced TNFα production (Sawle et al., 2005; Megias et al., 2007; Motterlini et al., 2012).”
From Heme oxygenase 1 controls early innate immune response of macrophages to Salmonella Typhimurium infection: Heme oxygenase 1 expression affects Salmonella infection (2016) · cites this paper as Sawle et al., 2005
Citations
Cites
Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway
Otterbein, L. E., Bach, F. H., Alam, J., Soares, M., Tao Lu, H., Wysk, M., Davis, R. J., Flavell, R. A., & Choi, A. M. K. (2000) · Nature Medicine · doi:10.1038/74680 · Cited by 2,153
MacMicking, J. D., Nathan, C., Hom, G., Chartrain, N., Fletcher, D. S., Trumbauer, M., Stevens, K., Xie, Q.-W., Sokol, K., Hutchinson, N., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90085-3 · Cited by 1,444
Reduced stress defense in heme oxygenase 1-deficient cells
Poss, K. D., & Tonegawa, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10925 · Cited by 1,291
Stamler (2001) · doi:10.1016/s0092-8674(01)00495-0 · Cited by 1,261 · cited 2×
“…once CO is liberated, it will tightly bind to cellular targets that preserve CO bioactivity over time, in a manner similar to S-nitrosothiols, such as S-nitrosoalbumin and S-nitrosoglutathione (Stamler et al., 2001), which are long-lived species acting apparently as a reservoir of NO bioactivity.”
Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency
Yachie, A., Niida, Y., Wada, T., Igarashi, N., Kaneda, H., Toma, T., Ohta, K., Kasahara, Y., & Koizumi, S. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4165 · Cited by 1,255
Heme oxygenase-1: unleashing the protective properties of heme
Otterbein, L. E., Soares, M. P., Yamashita, K., & Bach, F. H. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00181-9 · Cited by 1,166
Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice
Lee, T.-S., & Chau, L.-Y. (2002) · Nature Medicine · doi:10.1038/nm0302-240 · Cited by 1,019
Carbon Monoxide-Releasing Molecules: Characterization of Biochemical and Vascular Activities
Motterlini, R., Clark, J. E., Foresti, R., Sarathchandra, P., Mann, B. E., & Green, C. J. (2002) · Circulation Research · doi:10.1161/hh0202.104530 · Cited by 998
Heme oxygenase: A novel target for the modulation of inflammatory response
Willis, D., Moore, A. R., Frederick, R., & Willoughby, D. A. (1996) · Nature Medicine · doi:10.1038/nm0196-87 · Cited by 783
Cardioprotective Actions by a Water-Soluble Carbon Monoxide–Releasing Molecule
Clark, J. E., Naughton, P., Shurey, S., Green, C. J., Johnson, T. R., Mann, B. E., Foresti, R., & Motterlini, R. (2003) · Circulation Research · doi:10.1161/01.res.0000084381.86567.08 · Cited by 673
Research works printed but not linked: 1
- 10.1042/bj3480615 · doi:10.1042/bj3480615 · Paper page
Cited by
Items 201–300 of 389
A water-soluble carbon monoxide-releasing molecule (CORM-3) lowers intraocular pressure in rabbits
Stagni, E., Privitera, M. G., Bucolo, C., Leggio, G. M., Motterlini, R., & Drago, F. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.137034 · Cited by 39
“In this study we showed for the first time the importance of CO system in modulating intraocular pressure in two different glaucoma experimental models. Since CORM-3 causes the increase in HO-1 expression, we speculate that the mechanism of action of CORM-3 is due, at least in part, to this induction.”
Backgroundvan der Vlies, A. J., Inubushi, R., Uyama, H., & Hasegawa, U. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00135 · Cited by 38
Wareham, L. K., McLean, S., Begg, R., Rana, N., Ali, S. I., Kendall, J. J., Sanguinetti, G., Mann, B. E., & Poole, R. K. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7239 · Cited by 37
Mansour, A. M., Khaled, R. M., Tharwat, E. K., Ahmed, S. K., Ismael, O. S., Zeinhom, A., Magdy, H., Ibrahim, S. S., & Abdelfatah, M. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114991 · Cited by 37
Hewison, L., Crook, S. H., Mann, B. E., Meijer, A. J. H. M., Adams, H., Sawle, P., & Motterlini, R. (2012) · Organometallics · doi:10.1021/om3003637 · Cited by 35
Vadori, M., Seveso, M., Besenzon, F., Bosio, E., Tognato, E., Fante, F., Boldrin, M., Gavasso, S., Ravarotto, L., Mann, B. E., et al. (2009) · Xenotransplantation · doi:10.1111/j.1399-3089.2009.00521.x · Cited by 34
Leung, P., Wang, S., Lu, S.-H., Chou, W., Shiau, C., & Chou, T. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.09.004 · Cited by 37
Role of Carbon Monoxide in Vascular Diseases
Barbagallo, I., Marrazzo, G., Frigiola, A., Zappala, A., & Li Volti, G. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112800399086 · Cited by 33
“[25] Sawle, P.”
BackgroundYang, P., Huang, Y., Zhang, Y., Hsieh, C., & Wung, B. (2016) · Vascular Pharmacology · doi:10.1016/j.vph.2016.09.010 · Cited by 32
Osborne, D. G., Dunbar, J. A., Lapping, J. G., White, A. M., & Kubarych, K. J. (2013) · The Journal of Physical Chemistry B · doi:10.1021/jp4049428 · Cited by 32
GYY4137 attenuates LPS-induced acute lung injury via heme oxygenase-1 modulation
Jiang, L., Jiang, Q., Yang, S., Huang, S., Han, X., Duan, J., Pan, S., Zhao, M., & Guo, S. (2018) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2018.12.004 · Cited by 32
Spontaneous CO Release from RuII(CO)2–Protein Complexes in Aqueous Solution, Cells, and Mice
Chaves‐Ferreira, M., Albuquerque, I. S., Matak‐Vinković, D., Coelho, A. C., Carvalho, S. M., Saraiva, L. M., Romão, C. C., & Bernardes, G. J. L. (2014) · Angewandte Chemie · doi:10.1002/ange.201409344 · Cited by 32
Hou, C.-C., Huang, C., & Shyur, L. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf202958r · Cited by 37
Reactive Oxygen Species-Activated Metal-Free Carbon Monoxide Prodrugs for Targeted Cancer Treatment
Li, Z., Wang, Y.-M., Liu, M., Pan, Y., Ni, Z., Min, Q., Wang, B., Ke, H., & Ji, X. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01056 · Cited by 31
Carbon monoxide releasing molecule-2 ameliorates IL-1β-induced IL-8 in human gastric cancer cells
Lian, S., Xia, Y., Ung, T. T., Khoi, P. N., Yoon, H. J., Kim, N. H., Kim, K. K., & Jung, Y. D. (2016) · Toxicology · doi:10.1016/j.tox.2016.07.003 · Cited by 33
“…properties via inhibition of NADPH oxidase (Taillé et al. 2005). iii) CO attenuates the inflammatory response elicited by lipopolysaccharide (Sawle et al. 2005) or cytokines (Megias et al. 2007). iv) CO inhibits various genes, including eukaryotic elongation factor-2 (Schwer et al. 2013),…”
BackgroundWang, P., Yao, L., Zhou, L., Liu, Y., Chen, M., Wu, H., Chang, R., Li, Y., Zhou, M., Fang, X., et al. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.13222 · Cited by 33
“The inactive form of CORM-2 (iCORM-2) was prepared as described [18].”
MethodJun, M. S., Kim, H. S., Kim, Y., Kim, H. J., Park, E., Lee, J. H., Lee, K. R., Kim, Y. S., & Chang, K. C. (2011) · Phytotherapy Research · doi:10.1002/ptr.3613 · Cited by 32
“Sepsis is a serious medical condition, which is associated with an uncontrolled inflammatory response to bacterial infection (Oh et al., 2009; Sawle et al., 2005).”
BackgroundLee, G.-Y., Zeb, A., Kim, E.-H., Suh, B., Shin, Y., Kim, D., Kim, K.-W., Choe, Y.-H., Choi, H.-I., Lee, C., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.05.010 · Cited by 30
Li, Y., Zhang, L., Zhang, D., Zheng, W., Bai, Y., Bai, J., Fu, L., & Wang, X.-P. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104842 · Cited by 30
Berrino, E., Carradori, S., Angeli, A., Carta, F., Supuran, C. T., Guglielmi, P., Coletti, C., Paciotti, R., Schweikl, H., Maestrelli, F., et al. (2021) · Antioxidants · doi:10.3390/antiox10010056 · Cited by 30
Hsu, C., Vo, T. T. T., Lee, C., Chen, Y., Lin, W., Cheng, J. H.-C., Vo, Q. C., & Lee, I. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114978 · Cited by 30
Metalloimmunotherapy with Rhodium and Ruthenium Complexes: Targeting Tumor‐Associated Macrophages
Toupin, N. P., Herroon, M. K., Thummel, R. P., Turró, C., Podgorski, I., Gibson, H. M., & Kodanko, J. J. (2022) · Chemistry - A European Journal · doi:10.1002/chem.202104430 · Cited by 33
Sun, B., Chen, Z., Chen, X., & Liu, C. (2007) · Journal of Burn Care & Research · doi:10.1097/bcr.0b013e31802ca491 · Cited by 32
Liu, X., Zhang, Z., Cheng, Z., Zhang, J., Xu, S., Liu, H., Jia, H., & Jin, Y. (2015) · Pain Medicine · doi:10.1111/pme.12906 · Cited by 32
Hewison, L., Johnson, T. R., Mann, B. E., Meijer, A. J. H. M., Sawle, P., & Motterlini, R. (2011) · Dalton Transactions · doi:10.1039/c1dt10338e · Cited by 29
García-Arnandis, I., Guillén, M. I., Sancho, F. G., Castejón, M. A., & Alcaraz, M. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024591 · Cited by 30
“In some cellular systems, CO-RMs have been shown to induce HO-1 [9].”
BackgroundInfluentialThe interrelationship between gasotransmitters and lead-induced renal toxicity in rats
Abdel‐Zaher, A. O., Abd-ellatief, R. B., Aboulhagag, N. A., Farghaly, H. S. M., & AL-Wasei, F. M. M. (2019) · Toxicology Letters · doi:10.1016/j.toxlet.2019.04.012 · Cited by 30
Postischemic cardiac recovery in heme oxygenase-1 transgenic ischemic/reperfused mouse myocardium
Juhász, B., Varga, B., Czompa, A., Bak, I., Lekli, I., Gesztelyi, R., Zsuga, J., Kemény‐Beke, Á., Antal, M., Szendrei, L., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01153.x · Cited by 32
“death caused by various pathological processes [7-10].”
Lee, D., Lee, M., Sung, S. H., & Jeong, G. S. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.08.030 · Cited by 29
Dreyer-Andersen, N., Almeida, A. S., Jensen, P., Kamand, M., Okarmus, J., Rosenberg, T., Friis, S. D., Martínez-Serrano, A., Blaabjerg, M., Kristensen, B. W., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191207 · Cited by 32
Gao, C., Liang, X., Guo, Z., Jiang, B., Liu, X., & Shen, X. (2018) · ACS Omega · doi:10.1021/acsomega.8b00052 · Cited by 28
Regulation of microglial migration, phagocytosis, and neurite outgrowth by HO‐1/CO signaling
Scheiblich, H., & Bicker, G. (2014) · Developmental Neurobiology · doi:10.1002/dneu.22253 · Cited by 29
“In an inflammatory model system of LPS-induced murine macrophages, treatment with exogenous CO inhibited the expression of pro-inflammatory cytokines (Otterbein et al., 2000; Sawle et al. 2005), and decreased the release of nitric oxide (NO) in human umbilical vein endothelial cells (Qin et al.”
BackgroundBabu, D., Soenen, S. J., Raemdonck, K., Leclercq, G., Backer, O. D., Motterlini, R., & Lefebvre, R. A. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802481291 · Cited by 29
“[52] Sawle P, Foresti R, Mann BE, Johnson TR, Green CJ, Motterlini R.”
BackgroundSun, B., Jin, Q., Sun, Y., Sun, Z., Chen, X., Chen, Z., & Cepinskas, G. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i46.6183 · Cited by 31
Ryu, J. H., Park, H., Jeong, Y., Han, S., Shin, J., Lee, S. J., Kang, M. J., Sung, N., & Kang, D. (2015) · Journal of Medicinal Food · doi:10.1089/jmf.2014.3214 · Cited by 26
“The metabolites, such as biliverdin/ bilirubin and carbon monoxide, decrease NO production and iNOS expression in LPS-stimulated macrophages.(24,25) ARGE-induced activation of nuclear factor erythroid 2related factor 2 (Nrf2) produced a significant increase in HO-1 expression.”
Lazarus, L. S., Dederich, C. T., Anderson, S. N., Benninghoff, A. D., & Berreau, L. M. (2022) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00595 · Cited by 26
Haas, B., Chrusciel, S., Fayad‐Kobeissi, S., Dubois‐Randé, J., Azuaje, F. J., Boczkowski, J., Motterlini, R., & Foresti, R. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24844 · Cited by 26
“Results were expressed as pmol bilirubin/mg of protein/h. Western immunoblotting HO-1 protein expression was determined in cell samples treated as for the heme oxygenase activity assay (Sawle et al., 2005; Sawle et al., 2008).”
MethodTherapeutic roles of carbon monoxide in intestinal ischemia‐reperfusion injury
Katada, K., Takagi, T., Uchiyama, K., & Naito, Y. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12742 · Cited by 30
CO liberated from CORM-2 modulates the inflammatory response in the liver of thermally injured mice
Sun, B., Sun, Y., Sun, Z., & Chen, X. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.547 · Cited by 29
Therapeutic Potential of Carbon Monoxide (CO) for Intestinal Inflammation
Naito, Y., Uchiyama, K., Takagi, T., & Yoshikawa, T. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803413935 · Cited by 26
“In this system, application of CORMs resulted in secondary activation of HO-1 [30].”
MethodShen, H., Huang, S.-Y., Cheng, P., Chu, Y., Chen, S., Lam, K., & Lee, Y. (2017) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000000864 · Cited by 26
Carbon monoxide-releasing molecule, CORM-3, modulates alveolar macrophage M1/M2 phenotype in vitro
Yamamoto-Oka, H., Mizuguchi, S., Toda, M., Minamiyama, Y., Takemura, S., Shibata, T., Cepinskas, G., & Nishiyama, N. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0371-y · Cited by 26
“…depending on: (1) the rate and amount of CO release from CORMs, (2) proximity of the heme-containing proteins, and (3) the cell type investigated (Hoetzel et al. 2007; Foresti et al. 2008; Piantadosi 2008; Mizuguchi et al. 2009; Sawle et al. 2005; Sarady et al. 2004; Boczkowski et al. 2006).”
BackgroundInfluentialSoni, H., Jain, M. R., & Mehta, A. A. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.02.009 · Cited by 25
“CORM-3 ((tricarbonylchloro(glycinato) ruthenium(II)) has a unique feature of being fully water-soluble and has been shown to simulate the bioactivities of gaseous CO including vessel relaxation [31], protection against I/R injury [6] , prevention of organ rejection following transplantation [6] and inhibition of the i…”
BackgroundInoue, K., Patterson, E. K., Capretta, A. A., Lawendy, A., Fraser, D. D., & Cepinskas, G. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.12.025 · Cited by 24
Naphthalimide derivatives as fluorescent probes for imaging endogenous gasotransmitters
Ranjana, M., & Sunil, D. (2022) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2022.110022 · Cited by 24
Qin, W., Zhang, J., Lv, W., Wang, X., & Sun, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075840 · Cited by 24
“CORM-2 also has exhibited anti-inflammatory actions in an in vitro model of LPS-stimulated macrophages [45].”
BackgroundPark, P., Hur, J., Kim, Y., An, R., & Sohn, D. H. (2011) · Archives of Pharmacal Research · doi:10.1007/s12272-011-0917-2 · Cited by 25
“reported that treatment of macrophages with CO, a by-product of heme degradation by HO-1, inhibited LPS-induced nitrite production without affecting iNOS protein expression (Sawle et al., 2005).”
BackgroundUddin, M. J., Li, C., Joe, Y., Chen, Y., Zhang, Q., Ryter, S. W., & Chung, H. (2015) · Mediators of Inflammation · doi:10.1155/2015/613249 · Cited by 27
“In addition, RuCl 3, a negative control for CORM-2, did not affect LPS-mediated TN-C, TNF-𝛼, and IL-6 expression in macrophages or in septic mice.”
BackgroundSchwer, C. I., Stoll, P., Rospert, S., Fitzke, E., Schallner, N., Bürkle, H., Schmidt, R., & Humar, M. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.09.020 · Cited by 26
Pradhan, A. K., Umezu, M., & Fukagawa, M. (2006) · American Journal of Nephrology · doi:10.1159/000098001 · Cited by 25
“have demonstrated the significant relationship between oxidative stress, vascular injury and salt-sensitive HTN by showing that NADPH oxidase-dependent elevation in ROS contributes to salt-sensitive HTN. In another study [”
BackgroundLee, S.-N., Kim, E.-Y., Jeon, W.-K., Woo, C.-H., Choe, J., Han, S., & Kim, B.-C. (2010) · Biochimie · doi:10.1016/j.biochi.2010.09.007 · Cited by 23
Filippo, C. D., Perretti, M., Rossi, F., Ferraraccio, F., Motterlini, R., & D’Amico, M. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0703-1 · Cited by 23
Megías, J., Guillén, M. I., Bru, A., Gomar, F., & Alcaraz, M. J. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134650 · Cited by 24
“56 derived from heme oxygenase-1 (HO-1) activity (for review, see Foresti et al., 2005).”
BackgroundInfluentialLin, C., Hsiao, L., Cho, R., & Yang, C. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040436 · Cited by 22
“A previous report indicated that CORMs can upregulate HO-1 activity and attenuate the LPS-induced inflammatory responses in macrophage cell lines [7] and animal studies [6,36].”
BackgroundCarbon monoxide protects against ovariectomy-induced bone loss by inhibiting osteoclastogenesis
Phan, T. V., Sul, O., Ke, K., Lee, M., Kim, W.-K., Cho, Y.-S., Kim, H., Kim, S., Chung, H., & Choi, H. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.01.014 · Cited by 22
Choi, E., Choe, S.-H., Hyeon, J.-Y., Choi, J., Choi, I. S., & Kim, S. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.06.039 · Cited by 22
“7 cells was reported by Sawle et al. (2005); CORM-3 diminished LPS-induced NO generation in a concentration-dependent manner without affecting the iNOS protein level.”
BackgroundMethodPark, E., Jang, H. J., Tsoyi, K., Kim, Y. M., Park, S. W., Kim, H. J., Lee, J. H., & Chang, K. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076293 · Cited by 23
“Much attention has been paid to CO and COreleasing molecules (CORMs) due to their ability to attenuate inflammatory responses in many different experimental models [12–17].”
BackgroundYang, S., Chen, M., Zhou, L., Zhang, G., Gao, Z., & Zhang, W. (2016) · Dalton Transactions · doi:10.1039/c5dt04479k · Cited by 21
Datta, P., Sardar, D., Mukhopadhyay, A. P., López‐Torres, E., Pastor, C. J., & Sinha, C. (2010) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2010.08.025 · Cited by 21
Interaction of carbon monoxide-releasing ruthenium carbonyl CORM-3 with plasma fibronectin
Aki, T., Unuma, K., Noritake, K., Kurahashi, H., Funakoshi, T., & Uemura, K. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2018.03.010 · Cited by 20
Park, P., Kim, H. S., Hur, J., Jin, X. Y., Jin, Y., & Sohn, D. H. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-1121-5 · Cited by 21
Ke, Y.-Y., Shyu, Y., & Wu, S. (2021) · Foods · doi:10.3390/foods10010167 · Cited by 19
“Treatment of cells with LPS causes an inflammatory response, which promotes upregulation of iNOS in macrophages affected by the inflammatory response, leading to a massive increase in the production of NO [49].”
BackgroundLiu, Y., Sun, X., Liu, J., Kang, Z., & Deng, X. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05560.x · Cited by 20
Zrelli, H., Wu, C.-W., Zghonda, N., Shimizu, H., & Miyazaki, H. (2013) · BioMed Research International · doi:10.1155/2013/912431 · Cited by 19
“CORM-3 reduced inflammatory responses both in vitro and in vivo [22, 23].”
BackgroundImmune response to stem cells and strategies to induce tolerance
Batten, P., Rosenthal, N. A., & Yacoub, M. H. (2007) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2007.2120 · Cited by 23
“In addition, recent data from Sawle et al. (2005, 2006) have demonstrated that anti-inflammatory responses can be suppressed by novel metal carbonyl-based compounds or CO-releasing molecules (CO-RMs).”
Sex-Dependent Effects of HO-1 Deletion from Adipocytes in Mice
Hosick, P. A., Weeks, M. L., Hankins, M., Moore, K. H., & Stec, D. E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030611 · Cited by 20
Soares, N. L., Paiva, I. I. P., Bravo, J., Queiroga, C. S. F., Melo, B. F., Conde, S. V., Romão, C. C., Summavielle, T., & Vieira, H. L. A. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02643-z · Cited by 24
Chi, P., Chuang, Y., Chen, Y., Lin, C., Hsiao, L., & Yang, C. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12680 · Cited by 19
“CORMs have potent anti-inflammatory effects, decreasing the production of inflammatory mediators and attenuating levels of NO and TNF-α in macrophages stimulated with LPS (Otterbein et al., 2000; Sawle et al., 2005).”
BackgroundThe Role of Carbon Monoxide as a Gasotransmitter in Cardiovascular and Metabolic Regulation
Untereiner, A. A., Wu, L., & Wang, R. (2012) · Springer eBooks · doi:10.1007/978-3-642-30338-8_2 · Cited by 22
“In other words, CO could act as a feedback inhibitor of iNOS when NO concentrations exceed the homeostatic threshold (Sawle et al. 2005).”
BackgroundLiu, T., Han, Q., Pan, Y., Li, J., & Song, H. (2021) · Inflammation · doi:10.1007/s10753-021-01450-x · Cited by 19
Nagasaki, T., Maeda, H., Taguchi, K., Yanagisawa, H., Nishida, K., Kobayashi, K., Wada, N., Noguchi, I., Murata, R., Sakai, H., et al. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102371 · Cited by 19
Liu, H., Wang, P., Zhao, Q., Chen, Y., Liu, B., Zhang, B., & Zheng, Q. (2014) · Applied Organometallic Chemistry · doi:10.1002/aoc.3105 · Cited by 18
Serizawa, F., Patterson, E. K., Potter, R. F., Fraser, D. D., & Cepinskas, G. (2014) · Microcirculation · doi:10.1111/micc.12161 · Cited by 18
“Recent studies in the field indicate that CO, a natural end product of HO activity in mammalian tissues exhibits potent anti-inflammatory effects [30,38,47].”
BackgroundMizuguchi, S., Capretta, A. A., Suehiro, S., Nishiyama, N., Luke, P. P. W., Potter, R. F., Fraser, D. D., & Cepinskas, G. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.08.017 · Cited by 22
“Carbon monoxide (CO) is one of the natural end-products of heme oxygenase activity in mammalian tissues, which degrades heme to produce biliverdin/bilirubin, ferrous iron, and CO [1,2].”
BackgroundSchoenfeld, M. P., Ansari, R. R., Nakao, A., & Wink, D. A. (2012) · Medical Gas Research · doi:10.1186/2045-9912-2-8 · Cited by 21
Suliman, H. B., Healy, Z. R., Zobi, F., Kraft, B. D., Welty‐Wolf, K. E., Smith, J. B., Barkauskas, C. E., & Piantadosi, C. A. (2021) · iScience · doi:10.1016/j.isci.2021.103535 · Cited by 20
RetractedGaseous Therapeutics in Acute Lung Injury
Ryter, S. W., & Choi, A. M. K. (2010) · Comprehensive physiology · doi:10.1002/cphy.c090003 · Cited by 19
Cheng, C., Chen, Y., Vo, T. T. T., Hong, Y. C., Wang, C., Vo, Q. C., Chou, H.-C., Huang, T.-W., & Lee, I. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115099 · Cited by 17
Schallner, N., Schwemmers, S., Schwer, C. I., Froehlich, C., Stoll, P., Humar, M., Pahl, H. L., Hoetzel, A., Loop, T., & Goebel, U. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.08.028 · Cited by 17
“Comparable cytoprotective properties of CO-RMs and carbonmonoxide have been characterized in models of inflammation, vascular dysfunction and ischemic injury (Lancel et al., 2009; Motterlini et al., 2002; Sawle et al., 2005; Song et al., 2002; Tsoyi et al., 2009; Urquhart et al., 2007).”
BackgroundResultGao, L., Cheng, J. G., Shen, Z., Zhang, G., Liu, S., & Hu, J. (2021) · Angewandte Chemie · doi:10.1002/ange.202112782 · Cited by 18
Strategies toward Metal‐Free Carbon Monoxide Prodrugs: An Update
Min, Q., & Ji, X. (2022) · ChemMedChem · doi:10.1002/cmdc.202200500 · Cited by 17
Tristetraprolin Mediates Anti-Inflammatory Effect of Carbon Monoxide against DSS-Induced Colitis
Joe, Y., Uddin, M. J., Zheng, M., Kim, H. J., Chen, Y., Yoon, N. A., Cho, G. J., Park, J. W., & Chung, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088776 · Cited by 16
“Inactive CORM-2 (iCORM-2) was used as a negative control [23] to assess whether the effects observed were due to the CO liberated by the CORM-2 or were caused by other components of the molecules.”
MethodShi, J., Yu, J., Zhang, Y., Li, Z., Gong, L., Dong, S., & Mu, R. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6448 · Cited by 18
Zhang, R., Pan, K., Hao, Y. T., Yip, C., & Ko, W. H. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.12.002 · Cited by 17
Sun, J., Kim, S. J., Park, M. K., Kim, H. J., Tsoy, I., Kang, Y. J., Lee, Y. S., Seo, H. G., Lee, J. H., & Chang, K. C. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.08.080 · Cited by 16
“the cells against inflammation or oxidative stress [31–34].”
BackgroundMetal Carbonyl Prodrugs: CO Delivery and Beyond
Romão, C. C., & Vieira, H. L. A. (2014) · Wiley eBooks · doi:10.1002/9783527673438.ch06 · Cited by 19
Černauskienė, I., Navo, C. D., Labão‐Almeida, C., Proctor, R. S. J., Gless, B. H., Khaw, W. T., Tang, C., Muriel-Olaya, M. M., Jiménez‐Osés, G., & Bernardes, G. J. L. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c05952 · Cited by 15
Water-Soluble Carbon Monoxide-Releasing Molecules (CORMs)
Khan, H., Faizan, M., Niazi, S. U. K., Madiha, Muhammad, N., & Zhang, W. (2022) · Topics in Current Chemistry · doi:10.1007/s41061-022-00413-6 · Cited by 15
Kim, M. J., Kadayat, T. M., Kim, D. E., Lee, E.-S., & Park, P. (2014) · Biomolecules & Therapeutics · doi:10.4062/biomolther.10.4062/biomolther.2014.062 · Cited by 15
Hu, M., Zhu, B., Zhou, H., Qiao, L., Fan, J., Du, Y., Chang, F., & Yu, S. (2020) · Inorganic Chemistry Communications · doi:10.1016/j.inoche.2020.108093 · Cited by 15
Obara, T., Yamamoto, H., Aokage, T., Igawa, T., Nojima, T., Hirayama, T., Seya, M., Ishikawa‐Aoyama, M., Nakao, A., Motterlini, R., et al. (2021) · Transplantation · doi:10.1097/tp.0000000000004007 · Cited by 15
“Our data on the anti-inflammatory effects of CORM-3 in the intestine following transplantation are in line with previous data showing that both CO gas and CO liberated by CORMs differentially affect cytokine production by decreasing the expression of proinflammatory interleukins and increasing the expression of anti-i…”
BackgroundTherapeutic potential of nitric oxide modulation in ocular diseases
Drago, F., & Bucolo, C. (2010) · Drug News & Perspectives · doi:10.1358/dnp.2010.23.7.1484488 · Cited by 15
Yang, X., Mao, Q., & Wang, B. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.3c00750 · Cited by 15
Carbon monoxide induces cyclooxygenase-2 expression through MAPKs and PKG in phagocytes
Lin, L.-C., Ho, F., Yen, S.-J., Wu, P., Hung, L.-F., Huang, W., & Liang, Y. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.08.026 · Cited by 14
“Several researchers have demonstrated that CO can suppress inflammation through down-regulation of inducible nitric oxide synthase (iNOS), TNFα, or other pro-inflammatory cytokines in macrophage [18,19].”
BackgroundDong, S., Zhang, Y., Yu, J., Li, X., Gong, L., Shi, J., & Kang, Y. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.03.042 · Cited by 15
Thomas, J. M., Vidhyapriya, P., Sivan, A. K., Sakthivel, N., & Sivasankar, C. (2022) · Applied Organometallic Chemistry · doi:10.1002/aoc.6685 · Cited by 14
Choi, E., Park, H.-J., Sul, O., Rajasekaran, M., Yu, R., & Choi, H. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00458.2014 · Cited by 14
Lee, D., Choi, H.-G., Woo, K. W., Kang, D. G., Lee, H.-S., Oh, H., Lee, K. R., & Kim, Y. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.05.033 · Cited by 14
“The levels of TNF-α and IL-1β present in each sample were determined using a commercially available kit from R&D Systems (Sawle et al., 2005).”
MethodCarbon monoxide: from silent killer to potential remedy
Hill‐Kapturczak, N., & Agarwal, A. (2006) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00495.2005 · Cited by 14
Zhou, J.-L., Li, G., Hai, Y., Guan, L., Huang, X., & Sun, P. (2009) · PubMed · Cited by 13
Metadata
- Authors
- Sawle, P., Foresti, R., Mann, B. E., Johnson, T. R., Green, C. J., & Motterlini, R.
- Affiliations
- Northwick Park Institute for Medical Research (GB)
- University of Sheffield (GB)
- Corresponding author
- Motterlini, Roberto
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2005-07
- Volume
- 145
- Issue
- 6
- Pages
- 800-810
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1576195
- OpenAlex
- W2094470927
- Cited by
- 391
- References
- 36
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 7 · 2023: 7 · 2022: 16 · 2021: 22 · 2020: 16 · 2019: 10 · 2018: 18 · 2017: 14 · 2016: 16 · 2015: 20 · 2014: 21 · 2013: 24 · 2012: 25
- FWCI
- 10.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- British Heart Foundation
- Dunhill Medical Trust
- Engineering and Physical Sciences Research Council (GR/S30924/01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- carbon monoxide-releasing molecules, CORM-2, CORM-3, carbon monoxide, heme oxygenase-1, lipopolysaccharide, macrophages, RAW 264.7 macrophages, nitric oxide, inducible nitric oxide synthase, TNF-α, inflammation, anti-inflammatory activity, N-acetylcysteine
- MeSH terms
- Animals, Carbon Monoxide, Cell Line, Cell Survival, Glutathione, Heme Oxygenase (Decyclizing), Inflammation, Lipopolysaccharides, Macrophages, Membrane Proteins, Nitrites, Organometallic Compounds, Tumor Necrosis Factor-alpha, Nitric Oxide Synthase, Mice, Heme Oxygenase-1, Nitric Oxide Synthase Type II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.